LFTD Partners Inc. ( LIFD) - Key Metrics
LIFD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.61 | $0.04 | $0.05 | $0.05 |
| 2025Q2 | $0.70 | -$0.02 | -$0.02 | -$0.02 |
| 2025Q1 | $0.62 | -$0.02 | $0.02 | $0.02 |
| 2024Q4 | $0.57 | $0 | -$0.06 | -$0.06 |
| 2024Q3 | $0.59 | -$0.01 | -$0.02 | -$0.02 |
LIFD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | 0.71% | 1.69 |
| 2025Q2 | -1.67% | -5.37 |
| 2025Q1 | -0.99% | -3.91 |
| 2024Q4 | 126.56% | 1531.01 |
| 2024Q3 | -2.32% | -5.73 |
LIFD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 16.20% | 0.10% |
| 2025Q2 | -4.72% | 0.08% |
| 2025Q1 | 5.79% | 0.06% |
| 2024Q4 | -12.34% | 0.02% |
| 2024Q3 | -7.52% | 0.10% |
LIFD
Price: $0.18
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: -4
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 2.7 million